Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Trade Name
Risk Category
  • Positive evidence of human fetal risk exists.
  • Potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g. life threatening situations or serious illness).
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

  • A systemic antineoplastic agent.
  • Fetal Risk
    Fetal Risk
  • Limited human data but not reported to cause congenital anomalies.
  • Occupational exposure of pregnant women to antineoplastic agents in general presents a risk to the fetus including fetal loss and malformations.
  • Contraceptive methods should be considered during treatment with antineoplastic agents.
  • Breast Feeding
    Breast Feeding
  • Breast feeding is not recommended while using antineoplastic agents due to its side effets, mutagenicity and carcinogenicity.
  • Other Trade Names
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        Your Friend
     10   +   2    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Month Day Year